Travere Therapeutics (NasdaqGM:TVTX) Q3 2026 Earnings call November 02, 2026 04:30 PM ET Company ParticipantsEric Dube - President and CEOPeter Heerma - Chief Commercial OfficerJula Inrig - Head of R&D and Chief Medical OfficerChris Cline - CFOLaura Chico - Managing Director, Co-Head of Healthcare ResearchJoe Schwartz - Managing DirectorGavin Clark-Gartner - Managing DirectorPrakhar Agrawal - Managing DirectorSadia Rahman - Vice PresidentAlex Thompson - Research Managing DirectorVamil Divan - Managing Direc ...

Travere Therapeutics (NasdaqGM:TVTX) Q3 2026 Earnings call November 02, 2026 04:30 PM ET Speaker0Good afternoon, and welcome to the Travere Therapeutics Third Quarter 2026 Financial Results Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over to Ryan Hayes, Investor Relations Analyst. Please go ahead, Ryan.Speaker1Thank you, operator. Good afternoon, and welcome to Travere Therapeutics' Third Quarter 2026 Financial Results and Corporate Update Call. Th ...